Canopy Growth is a leading global cannabis company that produces, distributes, and sells cannabis and cannabis-related products for both medical and adult-use markets across Canada, Europe, and Australia. The company operates through two primary segments: a cannabis business offering dried flower, extracts, edibles, and other cannabis products under medical and consumer brands, along with clinic-based medical services in Canada; and Storz & Bickel, which manufactures and sells medical and consumer vaporization devices internationally. Canopy generates revenue through direct-to-patient medical cannabis e-commerce sales, provincial and retail supply agreements for adult-use products, international medical cannabis exports, vaporizer device sales, and an equity stake in a U.S. cannabis investment vehicle, while emphasizing brand leadership and cultivation excellence across its diversified portfolio.